SCHEMBL8429013

SCHEMBL8429013

BrCc1nn(Cc2ccccc2)c2c1CCCC2

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
SLC2A1 P11166 1/20 0.44
HTR7 P34969 2/20 0.42
HTR1A P08908 1/20 0.42
HTR2A P28223 1/20 0.42
LMNA P02545 1/20 0.42
TSHR P16473 1/20 0.42
HTT P42858 1/20 0.42
RAB9A P51151 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
FABP4 P15090 4/20 0.41
FABP3 P05413 1/20 0.41
CA1 P00915 3/20 0.40
CA2 P00918 3/20 0.40
PDE4A P27815 1/20 0.38
PDE4B Q07343 1/20 0.38
PDE4C Q08493 1/20 0.38
PDE4D Q08499 1/20 0.38
HTR2C P28335 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8430774 0.85 MEN1 (0.47) MEN1KMT2ASLC2A1HTR7HTR1A
SCHEMBL10479729 0.82 LMNA (0.46) MEN1KMT2ASLC2A1HTR7HTR1A
SCHEMBL2716199 0.79 MEN1 (0.49) MEN1KMT2ASLC2A1HTR7HTR1A
SCHEMBL22593912 0.76 TSHR (0.48) MEN1KMT2ASLC2A1HTR7HTR1A
SCHEMBL182481 0.75 MEN1 (0.49) MEN1KMT2ASLC2A1HTR7HTR1A
SCHEMBL182893 0.75 FABP4 (0.49) MEN1KMT2ASLC2A1LMNATSHR
SCHEMBL2715130 0.74 MEN1 (0.45) MEN1KMT2ASLC2A1HTR7HTR1A
SCHEMBL300478 0.74 FABP4 (0.50) MEN1KMT2ASLC2A1TSHRFABP4
SCHEMBL10216949 0.74 MEN1 (0.48) MEN1KMT2ASLC2A1HTR7HTR1A
SCHEMBL14027598 0.74 ALDH1A1 (0.40) MEN1KMT2ASLC2A1HTR7HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5859007-A TREATMENT OF DIABETES, OBESITY GLAXO WELLCOME INC. (US) 1999-01-12 US disclosed